Partial-onset Epilepsy
📧 Sign up to get email alerts when something new happens for Partial-onset Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Surgery as a Treatment for Medically Intractable Epilepsy
NINDS-sponsored trial is evaluating surgery as a treatment for medically intractable epilepsy, with recruitment currently ongoing.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy [Phase 4]
Open-label Phase 4 study evaluating cenobamate monotherapy in adults with newly diagnosed or recurrent partial-onset epilepsy; the trial is …
-
CLINICAL_TRIALS withdrawal · 2015-02-10Clinical Trial Update: To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures [Phase 4]
A Phase 4 clinical trial evaluating the effect of perampanel on sleep in individuals with insomnia and partial-onset epilepsy has been withd…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy. [Phase 4]
A Phase 4 trial assessed whether adjunctive levetiracetam affects sleep architecture in adults with partial-onset epilepsy; the study has co…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: A Study to Investigate the Potential Pharmacokinetic Interaction of Perampanel With Oral Contraceptives in Healthy Female Subjects [Phase 1]
Phase 1 study completed to evaluate potential pharmacokinetic interactions between perampanel and oral contraceptives in healthy female subj…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: A Study to Demonstrate Bioequivalence Between 6 x 2 mg Tablets of Perampanel and a Single 12 mg Tablet of Perampanel in Healthy Subjects [Phase 1]
This Phase 1 bioequivalence study evaluated whether six 2 mg tablets of perampanel are bioequivalent to a single 12 mg tablet in healthy sub…